Feng Yang is an Executive Director of Clinical Pharmacology and Pharmacometrics at Structure Therapeutics, bringing over 15 years of experience in clinical pharmacometrics, system biology, and drug development. Previously, Feng held leadership positions at Alexion Pharmaceuticals and Regeneron, where they oversaw quantitative pharmacology teams and executed modeling strategies for various therapeutic areas. Feng's academic background includes a Ph.D. in Chemical Engineering and a Master’s in Computer Science from the University of Rhode Island. They are known for their collaborative approach and commitment to delivering business value through innovative methodologies.
This person is not in any teams
This person is not in any offices